Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-29

Clinical Trial Update: Seasonal R21 Mass Vaccination for Malaria Elimination [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate the seasonal R21 malaria vaccine for malaria elimination. The study is sponsored by the London School of Hygi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R21 malaria vaccine (R21 malaria vaccine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: RECRUITING